Literature DB >> 15462484

Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: data from the LUMINA cohort.

A G Uribe1, K T Ho, B Agee, G McGwin, B J Fessler, H M Bastian, J D Reveille, G S Alarcón.   

Abstract

The aim of this study was to examine the relationship between nonadherence with study visits and with regularly scheduled clinic visits after adjusting for other patient and disease characteristics. One hundred and forty-one LUMINA patients with appointment data in the institutions' computerized systems (UAB and UTH) were studied. 'No shows' were assessed as the percentage of appointments not attended for either rheumatology, other clinics and LUMINA visits (from zero to 100%). Eighty-nine percent of the patients were women, 40% were Caucasians, 55% African-Americans and 5% Hispanics. 'No shows' to rheumatology were associated with non-Caucasian ethnicity, younger age, single marital status, lack of home ownership, 'no shows' to other clinics and to the LUMINA study, greater disease activity and to some disease manifestations (serositis, renal involvement, positive anti-dsDNA antibodies). In multivariable analyses, features predictive of rheumatology 'no shows' were lack of home ownership, 'no shows' to LUMINA study visits, renal involvement and serosal manifestations. Nonadherence with study visits and with regularly scheduled care at rheumatology clinics were associated. Other factors predictive of nonadherence to recommended care were lack of home ownership (a measurement of low socioeconomic status) and the presence of disease manifestations (i.e., renal or serosal involvement). These data should be considered when caring for patients with SLE.

Entities:  

Mesh:

Year:  2004        PMID: 15462484     DOI: 10.1191/0961203304lu1061oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Sofia de Achaval; Maria E Suarez-Almazor
Journal:  Int J Clin Rheumtol       Date:  2010-06-01

2.  Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.

Authors:  Laura Durcan; William A Clarke; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2015-10-01       Impact factor: 4.666

3.  Exacerbation history is associated with medication and appointment adherence in MS.

Authors:  Laura M Hancock; Jared M Bruce; Sharon G Lynch
Journal:  J Behav Med       Date:  2011-01-23

4.  Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Authors:  Gebre-Mariam Tsegay Hailu; Shemsu Umer Hussen; Seifemichael Getachew; Alemseged Beyene Berha
Journal:  BMC Nephrol       Date:  2022-06-17       Impact factor: 2.585

5.  Lupus nephritis flare in young patients: relapse or nonadherence to treatment?

Authors:  Francisco Rivera; Sara Anaya
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-03-27

6.  Frequency of Lost to Follow-Up and Associated Factors for Patients with Rheumatic Diseases.

Authors:  Ya-Chih Tien; Ying-Ming Chiu; Mei-Ping Liu
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.